市場調査レポート

商品コード

1192995

凝固検査市場：製品別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Coagulation Testing Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年10月01日 | 発行: Allied Market Research

| ページ情報: 英文 280 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,690 575,455円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,820 907,629円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,870 1,539,226円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.95円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の凝固検査市場規模は、2022年から2031年にかけてCAGR11.5%で2021年の31億170万米ドルから成長し、2031年までに87億7730万米ドルを獲得すると想定されています。

医療従事者は、止血システムを評価するために凝固検査を使用します。この検査には、血栓形成や血液凝固の速度を監視・評価する凝固計が主に使用されます。これらの検査により、血液動脈中の血栓の存在を検出することで、心臓発作、血栓症、塞栓症などのリスクを低減します。

血液の流れや血栓の形成を調節する複雑なプロセスである止血（凝固）は、数多くの酵素やタンパク質によって制御されています。

凝固検査装置の継続的な技術開拓の結果、市場は拡大しています。凝固検査市場の主な成長理由は、深部静脈血栓症（DVT）や血友病などのさまざまな血液凝固障害の有病率の上昇と、世界の高齢化です。この市場は、世界の凝固検査市場の成長に関する研究で包括的に評価されています。

経済的に可能である唯一の人口にその使用を制限する検査や治療に関連する高リスクとコストと一緒に厳しい政府の規制のために、世界の凝固検査市場に負の影響を与えます。

自己検査技術では、市場の成長を牽引しているスマートフォンベースの血液凝固検査装置が、抗凝固療法を受ける患者の血流を監視するのに役立っています。これらの要因が、凝固検査市場の需要を促進しています。

COVID-19のパンデミックは、多くの企業の世界のシャットダウンの結果として、重要な経済的損失をもたらした多くの困難をもたらしました。輸出入の制限が設けられました。COVID-19のパンデミックは、世界の凝固検査市場に有益な影響を及ぼしました。数多くの政府機関が、コロナウイルスの大流行から企業が生き残るために多くの行動を起こしています。多くの政府機関が、コロナウイルスの大流行から企業が生き残るために、多くの行動を起こしています。

市場の定義と範囲
主な調査結果
- 主な投資ポケット
ポーターのファイブフォース分析
主要企業のポジショニング
市場力学
- 促進要因
- 抑制要因
- 機会
COVID-19 影響分析
バリューチェーン分析
市場シェア分析
規制ガイドライン
主要規制の分析
特許情勢

第4章凝固検査市場：製品別

概要
- 市場規模・予測
機器
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
消耗品
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第5章凝固検査市場：応用分野別

概要
- 市場規模および予測
プロトロンビン時間
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
活性化部分トロンボプラスチン時間
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
トロンビン時間
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
活性化凝固時間
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章凝固検査市場：エンドユーザー別

概要
- 市場規模・予測
病院
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場分析：国別
クリニカルラボラトリー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ポイントオブケア検査
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章凝固検査市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米の市場規模・予測：製品別
- 北米市場規模・予測：アプリケーション別
- 北米市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州市場規模・予測：製品別
- 欧州市場規模・予測：アプリケーション別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - 英国
  - フランス
  - スペイン
  - イタリア
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：製品別
- アジア太平洋地域の市場規模・予測：アプリケーション別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 中国
  - 日本
  - インド
  - 韓国
  - オーストラリア
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：製品別
- LAMEAの市場規模・予測：アプリケーション別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - UAE
  - 南アフリカ
  - LAMEAの残りの地域

第8章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第9章企業プロファイル

Alere Inc.
Nihon Kohden Corporation
F. Hoffmann-La Roche Ltd.
Sysmex Corporation
Thermo Fisher Scientific Inc.
Diagnostica Stago Sas
Helena Laboratories
Abbott Laboratories
Medtronic plc
Micropoint Biosciences

図表

LIST OF TABLES

TABLE 1. GLOBAL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. COAGULATION TESTING MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. COAGULATION TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. COAGULATION TESTING MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 5. COAGULATION TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 7. COAGULATION TESTING MARKET SIZE, FOR PROTHROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 8. COAGULATION TESTING MARKET FOR PROTHROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 10. COAGULATION TESTING MARKET FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. COAGULATION TESTING MARKET SIZE, FOR THROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 12. COAGULATION TESTING MARKET FOR THROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED CLOTTING TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 14. COAGULATION TESTING MARKET FOR ACTIVATED CLOTTING TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. GLOBAL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 16. COAGULATION TESTING MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. COAGULATION TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. COAGULATION TESTING MARKET SIZE, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 19. COAGULATION TESTING MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. COAGULATION TESTING MARKET SIZE, FOR POINT-OF-CARE TESTING, BY REGION, 2021-2031 ($MILLION)
TABLE 21. COAGULATION TESTING MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. COAGULATION TESTING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. COAGULATION TESTING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. COAGULATION TESTING MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 25. NORTH AMERICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. U.S. COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 30. U.S. COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 31. U.S. COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 32. CANADA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 33. CANADA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 34. CANADA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. MEXICO COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 36. MEXICO COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. MEXICO COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. EUROPE COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. GERMANY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. GERMANY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. GERMANY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. UNITED KINGDOM COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 46. UNITED KINGDOM COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. UNITED KINGDOM COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. FRANCE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. FRANCE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. FRANCE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. SPAIN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. SPAIN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. SPAIN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. ITALY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 55. ITALY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. ITALY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. REST OF EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. REST OF EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. REST OF EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. ASIA-PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. ASIA-PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. ASIA-PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. CHINA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. CHINA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. CHINA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. JAPAN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 68. JAPAN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 69. JAPAN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 70. INDIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. INDIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. INDIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. SOUTH KOREA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. SOUTH KOREA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. SOUTH KOREA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 81. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 83. LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. LAMEA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 86. BRAZIL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 87. BRAZIL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. BRAZIL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. SAUDI ARABIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. UAE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. UAE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. UAE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 95. SOUTH AFRICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 96. SOUTH AFRICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 97. SOUTH AFRICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 98. REST OF LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 99. REST OF LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101.ALERE INC.: COMPANY SNAPSHOT
TABLE 102.ALERE INC.: OPERATING SEGMENTS
TABLE 103.ALERE INC.: PRODUCT PORTFOLIO
TABLE 104.ALERE INC.: NET SALES,
TABLE 105.ALERE INC.: KEY STRATERGIES
TABLE 106.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 107.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
TABLE 108.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
TABLE 109.NIHON KOHDEN CORPORATION: NET SALES,
TABLE 110.NIHON KOHDEN CORPORATION: KEY STRATERGIES
TABLE 111.F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 112.F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 113.F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 114.F. HOFFMANN-LA ROCHE LTD.: NET SALES,
TABLE 115.F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
TABLE 116.SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 117.SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 118.SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 119.SYSMEX CORPORATION: NET SALES,
TABLE 120.SYSMEX CORPORATION: KEY STRATERGIES
TABLE 121.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 122.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 123.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 124.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 125.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 126.DIAGNOSTICA STAGO SAS: COMPANY SNAPSHOT
TABLE 127.DIAGNOSTICA STAGO SAS: OPERATING SEGMENTS
TABLE 128.DIAGNOSTICA STAGO SAS: PRODUCT PORTFOLIO
TABLE 129.DIAGNOSTICA STAGO SAS: NET SALES,
TABLE 130.DIAGNOSTICA STAGO SAS: KEY STRATERGIES
TABLE 131.HELENA LABORATORIES: COMPANY SNAPSHOT
TABLE 132.HELENA LABORATORIES: OPERATING SEGMENTS
TABLE 133.HELENA LABORATORIES: PRODUCT PORTFOLIO
TABLE 134.HELENA LABORATORIES: NET SALES,
TABLE 135.HELENA LABORATORIES: KEY STRATERGIES
TABLE 136.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 137.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 138.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 139.ABBOTT LABORATORIES: NET SALES,
TABLE 140.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 141.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 142.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 143.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 144.MEDTRONIC PLC: NET SALES,
TABLE 145.MEDTRONIC PLC: KEY STRATERGIES
TABLE 146.MICROPOINT BIOSCIENCES: COMPANY SNAPSHOT
TABLE 147.MICROPOINT BIOSCIENCES: OPERATING SEGMENTS
TABLE 148.MICROPOINT BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 149.MICROPOINT BIOSCIENCES: NET SALES,
TABLE 150.MICROPOINT BIOSCIENCES: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.COAGULATION TESTING MARKET SEGMENTATION
FIGURE 2.COAGULATION TESTING MARKET,2021-2031
FIGURE 3.COAGULATION TESTING MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.COAGULATION TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.VALUE CHAIN ANALYSIS
FIGURE 13.MARKET SHARE ANALYSIS
FIGURE 14.REGULATORY GUIDELINES
FIGURE 15.KEY REGULATION ANALYSIS
FIGURE 16.PATENT ANALYSIS BY COMPANY
FIGURE 17.PATENT ANALYSIS BY COUNTRY
FIGURE 18.COAGULATION TESTING MARKET,BY PRODUCT,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 21.COAGULATION TESTING MARKET,BY APPLICATION,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PROTHROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ACTIVATED PARTIAL THROMBOPLASTIN TIME COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF THROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF ACTIVATED CLOTTING TIME COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 26.COAGULATION TESTING MARKET,BY END USER,2021(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE TESTING COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHERS COAGULATION TESTING MARKET,2021-2031(%)
FIGURE 31.COAGULATION TESTING MARKET BY REGION,2021
FIGURE 32.U.S. COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 33.CANADA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 34.MEXICO COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 35.GERMANY COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 36.UNITED KINGDOM COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 37.FRANCE COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 38.SPAIN COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 39.ITALY COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 40.REST OF EUROPE COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 41.CHINA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 42.JAPAN COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 43.INDIA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 44.SOUTH KOREA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 45.AUSTRALIA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 46.REST OF ASIA PACIFIC COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 47.BRAZIL COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 48.SAUDI ARABIA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 49.UAE COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 50.SOUTH AFRICA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 51.REST OF LAMEA COAGULATION TESTING MARKET,2021-2031($MILLION)
FIGURE 52. TOP WINNING STRATEGIES, BY YEAR
FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 55.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 56.COMPETITIVE DASHBOARD
FIGURE 57.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 58.ALERE INC..: NET SALES ,($MILLION)
FIGURE 59.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)
FIGURE 60.F. HOFFMANN-LA ROCHE LTD..: NET SALES ,($MILLION)
FIGURE 61.SYSMEX CORPORATION.: NET SALES ,($MILLION)
FIGURE 62.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)
FIGURE 63.DIAGNOSTICA STAGO SAS.: NET SALES ,($MILLION)
FIGURE 64.HELENA LABORATORIES.: NET SALES ,($MILLION)
FIGURE 65.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 66.MEDTRONIC PLC.: NET SALES ,($MILLION)
FIGURE 67.MICROPOINT BIOSCIENCES.: NET SALES ,($MILLION)

Product Code: A03148

The global coagulation testing market size is envisioned to garner $8,777.3 million by 2031, growing from $3,101.7 million in 2021 at a CAGR of 11.5% from 2022 to 2031.

Medical professionals use coagulation tests to evaluate the hemostasis system. A coagulometer, which monitors and assesses the rate of clot formation or blood coagulation, is mostly used to conduct this test. These examinations reduce the risk of heart attack, thrombosis, and embolism by detecting the presence of blood clots in blood arteries.

Hemostasis (coagulation), a complicated process that regulates blood flow and clot formation, is controlled by numerous enzymes and proteins.

The market is expanding as a result of ongoing technological developments in coagulation testing equipment. The key growth reasons for the coagulation testing market are the rising prevalence of different blood clotting disorders, including deep vein thrombosis (DVT) and haemophilia, as well as the global ageing population. The market is comprehensively evaluated in the study on the global coagulation testing market growth.

Due to stringent government regulations along with high risk and costs associated with tests and treatment which limits its usage to only the population which is economically capable gives a negative impact on the global coagulation testing markets.

In the self-testing technology, the smartphone-based blood coagulation testing device which is driving the growth of the market helps to monitors the blood flow in patients by undergoing an anticoagulant therapy. These factors drives the coagulation testing market demand.

The COVID-19 pandemic brought about a number of difficulties that resulted in significant economic losses as a result of the global shutdown of many firms. There were established import-export limitations. The COVID-19 pandemic has had a beneficial impact on the market for coagulation testing worldwide. Numerous government agencies are taking a number of actions to help businesses survive the coronavirus epidemic. Many government agencies are taking a number of actions to help businesses survive the coronavirus outbreak.

The key players profiled in this report include Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION., Abbott., Sysmex Corporation, BD Biosciences., and Danaher.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coagulation testing market analysis from 2021 to 2031 to identify the prevailing coagulation testing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the coagulation testing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global coagulation testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Instruments
Consumables

By Application

Prothrombin Time
Activated Partial Thromboplastin Time
Thrombin Time
Activated Clotting Time

By End User

Hospitals
Clinical Laboratories
Point-of-Care Testing
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest Of Asia Pacific
LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA
Key Market Players
- Alere Inc.
- Nihon Kohden Corporation
- F. Hoffmann-La Roche Ltd.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Diagnostica Stago Sas
- Helena Laboratories
- Abbott Laboratories
- Medtronic plc
- Micropoint Biosciences

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Value Chain Analysis
3.8.Market Share Analysis
3.9.Regulatory Guidelines
3.10.Key Regulation Analysis
3.11.Patent Landscape

CHAPTER 4: COAGULATION TESTING MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Instruments
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Consumables
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: COAGULATION TESTING MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Prothrombin Time
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Activated Partial Thromboplastin Time
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Thrombin Time
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Activated Clotting Time
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country

CHAPTER 6: COAGULATION TESTING MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Clinical Laboratories
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Point-of-Care Testing
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country

CHAPTER 7: COAGULATION TESTING MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Product
  - 7.2.5.1.2 Market size and forecast, by Application
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Product
  - 7.2.5.2.2 Market size and forecast, by Application
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Product
  - 7.2.5.3.2 Market size and forecast, by Application
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Product
  - 7.3.5.1.2 Market size and forecast, by Application
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 United Kingdom
  - 7.3.5.2.1 Market size and forecast, by Product
  - 7.3.5.2.2 Market size and forecast, by Application
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 France
  - 7.3.5.3.1 Market size and forecast, by Product
  - 7.3.5.3.2 Market size and forecast, by Application
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Spain
  - 7.3.5.4.1 Market size and forecast, by Product
  - 7.3.5.4.2 Market size and forecast, by Application
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Italy
  - 7.3.5.5.1 Market size and forecast, by Product
  - 7.3.5.5.2 Market size and forecast, by Application
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Product
  - 7.3.5.6.2 Market size and forecast, by Application
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 China
  - 7.4.5.1.1 Market size and forecast, by Product
  - 7.4.5.1.2 Market size and forecast, by Application
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 Japan
  - 7.4.5.2.1 Market size and forecast, by Product
  - 7.4.5.2.2 Market size and forecast, by Application
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 India
  - 7.4.5.3.1 Market size and forecast, by Product
  - 7.4.5.3.2 Market size and forecast, by Application
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 South Korea
  - 7.4.5.4.1 Market size and forecast, by Product
  - 7.4.5.4.2 Market size and forecast, by Application
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 Australia
  - 7.4.5.5.1 Market size and forecast, by Product
  - 7.4.5.5.2 Market size and forecast, by Application
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest Of Asia Pacific
  - 7.4.5.6.1 Market size and forecast, by Product
  - 7.4.5.6.2 Market size and forecast, by Application
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Product
  - 7.5.5.1.2 Market size and forecast, by Application
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Product
  - 7.5.5.2.2 Market size and forecast, by Application
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 UAE
  - 7.5.5.3.1 Market size and forecast, by Product
  - 7.5.5.3.2 Market size and forecast, by Application
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 South Africa
  - 7.5.5.4.1 Market size and forecast, by Product
  - 7.5.5.4.2 Market size and forecast, by Application
  - 7.5.5.4.3 Market size and forecast, by End User
  - 7.5.5.5 Rest of LAMEA
  - 7.5.5.5.1 Market size and forecast, by Product
  - 7.5.5.5.2 Market size and forecast, by Application
  - 7.5.5.5.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Alere Inc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Nihon Kohden Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 F. Hoffmann-La Roche Ltd.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Sysmex Corporation
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Thermo Fisher Scientific Inc.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Diagnostica Stago Sas
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Helena Laboratories
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Abbott Laboratories
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Medtronic plc
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Micropoint Biosciences
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments

凝固検査市場：製品別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Coagulation Testing Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章凝固検査市場：製品別

第5章凝固検査市場：応用分野別

第6章凝固検査市場：エンドユーザー別

第7章凝固検査市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: COAGULATION TESTING MARKET, BY PRODUCT

CHAPTER 5: COAGULATION TESTING MARKET, BY APPLICATION

CHAPTER 6: COAGULATION TESTING MARKET, BY END USER

CHAPTER 7: COAGULATION TESTING MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

凝固検査市場：製品別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Coagulation Testing Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 凝固検査市場：製品別

第5章 凝固検査市場：応用分野別

第6章 凝固検査市場：エンドユーザー別

第7章 凝固検査市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: COAGULATION TESTING MARKET, BY PRODUCT

CHAPTER 5: COAGULATION TESTING MARKET, BY APPLICATION

CHAPTER 6: COAGULATION TESTING MARKET, BY END USER

CHAPTER 7: COAGULATION TESTING MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章凝固検査市場：製品別

第5章凝固検査市場：応用分野別

第6章凝固検査市場：エンドユーザー別

第7章凝固検査市場：地域別

第8章企業情勢

第9章企業プロファイル